MRC1 and neoplasm: CM from LDHA-inhibited (genetically and pharmacologically) CT2A and GL261 cells impaired the expression of a pro-tumor macrophage marker arginase 1 (Arg1) and the percentage of pro-tumor CD68+CD206+ cells in Raw264.7 macrophages (Supplementary Fig. S15b–g).